Cancer cells adapt to varying stress conditions to survive through plasticity. Stem cells
exhibit a high degree of plasticity, allowing them to generate more stem cells or differentiate …

Despite an increase in the incidence of breast cancer worldwide, overall prognosis has
been consistently improving owing to the development of multiple targeted therapies and …

Biomaterial scaffolds mimicking the environment in metastatic organs can deconstruct
complex signals and facilitate the study of cancer progression and metastasis. Here we …

The pattern of delayed recurrence in a subset of breast cancer patients has long been
explained by a model that incorporates a variable period of cellular or tumor mass dormancy …

Female breast cancer emerged as the leading cancer type in terms of incidence globally in
2020. Although mortality due to breast cancer has improved during the past three decades …

In breast cancer patients, tumor heterogeneity is associated with prognosis and therapeutic
response; however, the epigenetic diversity that exists in primary tumors remains unknown …

Approximately 30% of breast cancer survivors deemed free of disease will experience
locoregional or metastatic recurrence even up to 30 years after initial diagnosis, yet how …

Breast cancer (BC) is the first worldwide most frequent cancer in both sexes and the most
commonly diagnosed in females. Although BC mortality has been thoroughly declining over …

Two fields of cancer research have emerged dealing with the biology of tumour cells
localised to the abluminal vascular surface: vessel co-option (VCo), a non-angiogenic mode …

Known as a diverse collection of neoplastic diseases, breast cancer (BC) can be
hyperbolically characterized as a dynamic pseudo-organ, a living organism able to build a …